ChromaDex discloses financial results for third-quarter 2009

ChromaDex Corporation, (OTC Bulletin Board: CDXC) a leader in phytochemical reference standards and contract research, today announced financial results for the third quarter of 2009. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended October 3, 2009.

As of October 3, 2009, cash, cash equivalents, and marketable securities totaled $501,425.

"We are very pleased with our performance this quarter," said Frank Jaksch, CEO and co-founder of ChromaDex. "Despite continued tough overall economic conditions we continue to grow our top line revenue."

Additional Financial Results & Notes

On a reported basis, ChromaDex recorded revenue during the third quarter of 2009 of $1,433,086 as compared to $1,069,003 for the same period in 2008. The net loss attributable to common stockholders for the thirteen weeks ended October 3, 2009, was $177,544 as compared to a net loss of $710,347 for the same period in 2008. The lower net loss in the third quarter of 2009 as compared to the same period in 2008 was primarily attributable to [non-recurring] expenses in 2008 related to a private placement and the reverse merger acquisition of Cody Resources, Inc. coupled with an increase in revenues. The Company notes that as a result of its closing of the reverse merger acquisition of Cody Resources, Inc. on June 20, 2008, investors are cautioned that the Company's historical performance for that year is not directly comparable.